Clinical Trials List
Protocol NumberC6461016
Not yet recruiting
2026-07-24 - 2032-07-21
Phase II/III
Not yet recruiting3
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 唐振育 無
- Hung-Yuan Yu 無
- Yun-Cheng Hsieh 無
- 邱乃祈 無
- San-Chi Chen 無
- Yi-Ping Hung 無
- 姜乃榕 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 劉奕廷 無
- Yung-Yeh Su 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chih-Hung Hsu 無
- 黃柏翔 無
- 莊建淮 無
- 陳敬左 無
- TSUNG-HAO LIU 無
- JHE-CYUAN GUO 無
- 陳國興 無
- 梁逸歆 無
- 陳柏邑 無
- 呂理駿 無
- 李佳真 無
- SUNG-HSIN KUO 無
- Ann-Lii Cheng 無
- 林宗哲 無
- 郭弘揚 無
- Ying-Chun Shen 無
- 張端瑩 無
- TA-CHEN HUANG 無
- YU-YUN SHAO 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
40 participants
